Skip to Content

Clinical Trials Search Results

Showing 1-2 of 2

Sorted By:

  • LCCC 1029

    A Multi-Center, Randomized, Placebo-Controlled Phase II Study of Regorafenib in Combination with FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) Versus Placebo with FOLFIRI as Second-Line Therapy in Patients with K-RAS or BRAF Mutant Metastatic Colorectal Cancer


    Patient Registry and Biospecimens Profiling Repository

Showing trials 1-2 of 2

Also in this Section